AT present around 4.8 million
Australians are living with some
form of incontinence, with that
figure set to skyrocket to 6.5m by
2030, according to a new report
entitled The Economic Impact of
Incontinence in Australia.
Current incontinence costs to the
health system of $271m per annum
are also set to jump to $450m as
the population ages, without
clinical advances and new policies
designed to combat the increase.
Set to launch during World
Continence Week next Mon, the
report’s authors also found that
over half of all current sufferers
were aged above 50, with 80% of
urinary incontinence sufferers
found to be women.
See www.continence.org.au.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Jun 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Jun 11
STRONG growth in Australia has helped MedAdvisor Solutions achieve robust results for FY24, with a revenue increase of 24.6% on the previous corresponding period to $122.1 million.
WESFARMERS has today reported strong growth in revenue across its Health division and its Australian Pharmaceutical Industries (API) subsidiary, despite a significant reduction in COVID-19 anti-viral product sales.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.